Cipla Beheer

Beheer criteriumcontroles 1/4

De CEO Cipla is Umang Vohra, benoemd in Sep2016, heeft een ambtstermijn van 8.17 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 222.10M, bestaande uit 36.7% salaris en 63.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.04% van de aandelen van het bedrijf, ter waarde ₹ 509.03M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.1 jaar en 2.8 jaar.

Belangrijke informatie

Umang Vohra

Algemeen directeur

₹222.1m

Totale compensatie

Percentage CEO-salaris	36.7%
Dienstverband CEO	8.2yrs
Eigendom CEO	0.04%
Management gemiddelde ambtstermijn	5.1yrs
Gemiddelde ambtstermijn bestuur	2.8yrs

Recente managementupdates

Recent updates

Cipla Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Nov 01

Earnings Update: Cipla Limited (NSE:CIPLA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

May 14

With EPS Growth And More, Cipla (NSE:CIPLA) Makes An Interesting Case

May 03

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Feb 14

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Jan 26

Getting In Cheap On Cipla Limited (NSE:CIPLA) Is Unlikely

Jan 08

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Nov 15

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Oct 05

Does Cipla (NSE:CIPLA) Have A Healthy Balance Sheet?

Aug 04

Is Cipla (NSE:CIPLA) A Risky Investment?

Mar 24

A Look At The Fair Value Of Cipla Limited (NSE:CIPLA)

Mar 06

Cipla (NSE:CIPLA) Has A Pretty Healthy Balance Sheet

Dec 11

Estimating The Fair Value Of Cipla Limited (NSE:CIPLA)

Aug 19

Cipla (NSE:CIPLA) Will Pay A Dividend Of ₹5.00

Jul 30

Cipla (NSE:CIPLA) Could Easily Take On More Debt

Jul 14

If EPS Growth Is Important To You, Cipla (NSE:CIPLA) Presents An Opportunity

Jul 01

Cipla Limited (NSE:CIPLA) Shares Could Be 34% Above Their Intrinsic Value Estimate

Apr 30

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Mar 23

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Dec 18

Analyse CEO-vergoeding

Hoe is Umang Vohra's beloning veranderd ten opzichte van Cipla's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	₹45b
Jun 30 2024	n/a	n/a	₹43b
Mar 31 2024	₹222m	₹82m	₹41b
Dec 31 2023	n/a	n/a	₹37b
Sep 30 2023	n/a	n/a	₹35b
Jun 30 2023	n/a	n/a	₹31b
Mar 31 2023	₹175m	₹80m	₹28b
Dec 31 2022	n/a	n/a	₹26b
Sep 30 2022	n/a	n/a	₹26b
Jun 30 2022	n/a	n/a	₹25b
Mar 31 2022	₹229m	₹75m	₹25b
Dec 31 2021	n/a	n/a	₹26b
Sep 30 2021	n/a	n/a	₹26b
Jun 30 2021	n/a	n/a	₹25b
Mar 31 2021	₹181m	₹20m	₹24b
Dec 31 2020	n/a	n/a	₹22b
Sep 30 2020	n/a	n/a	₹18b
Jun 30 2020	n/a	n/a	₹16b
Mar 31 2020	₹136m	₹20m	₹15b
Dec 31 2019	n/a	n/a	₹17b
Sep 30 2019	n/a	n/a	₹16b
Jun 30 2019	n/a	n/a	₹16b
Mar 31 2019	₹150m	₹20m	₹15b
Dec 31 2018	n/a	n/a	₹13b
Sep 30 2018	n/a	n/a	₹14b
Jun 30 2018	n/a	n/a	₹15b
Mar 31 2018	₹189m	₹20m	₹14b

Compensatie versus markt: De totale vergoeding ($USD 2.63M ) Umang } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 1.09M ).

Compensatie versus inkomsten: De vergoeding van Umang is het afgelopen jaar met meer dan 20% gestegen.

CEO

Umang Vohra (53 yo)

8.2yrs

Tenure

₹222,100,000

Compensatie

Mr. Umang Vohra, B.E., M.B.A. has been Global Chief Executive Officer, Managing Director and Executive Director of Cipla Limited since September 1, 2016. As Cipla’s MD & GCEO, Mr. Vohra’s priorities have b...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Umang Vohra	MD, Global CEO & Executive Director	8.2yrs	₹222.10m	0.040% ₹ 509.0m
Raju Mistry	President & Global Chief People Officer	5.6yrs	geen gegevens	geen gegevens
Pradeep Bhadauria	President & Global Chief Scientific Officer	4.7yrs	geen gegevens	geen gegevens
Ashish Adukia	Global Chief Financial Officer	2.3yrs	geen gegevens	geen gegevens
Dinesh Jain	Senior VP & Head of Corporate Finance	no data	geen gegevens	geen gegevens
Sneha Hiranandani	Chief Information Officer	less than a year	geen gegevens	geen gegevens
Diksha Maheshwari	Head of Investor Relations	no data	geen gegevens	geen gegevens
Rajendra Chopra	Compliance Officer & Company Secretary	7.8yrs	₹15.30m	geen gegevens
Heena Kanal	Senior Vice-President of Corporate Communications	no data	geen gegevens	geen gegevens
Jaideep Gogtay	Global Chief Medical Officer	less than a year	geen gegevens	geen gegevens
Anurag Mishra	Head of Cipla Foundation	no data	geen gegevens	geen gegevens
Kiran Pai	Head of Digital Marketing	7.8yrs	geen gegevens	geen gegevens

5.1yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CIPLA is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Umang Vohra	MD, Global CEO & Executive Director	8.2yrs	₹222.10m	0.040% ₹ 509.0m
Yusuf Hamied	Non-Executive Chairman	52.3yrs	₹26.10m	18.64% ₹ 237.2b
Punita Lal	Independent Non-Executive Director	10yrs	₹11.00m	geen gegevens
Adil Zainulbhai	Lead Independent Non-Executive Director	10.3yrs	₹10.10m	geen gegevens
Kamil Hamied	Non-Executive Director	less than a year	geen gegevens	1.35% ₹ 17.2b
Robert Stewart	Independent Director	3.5yrs	₹14.60m	geen gegevens
Sharmila Paranjpe	Independent Director	less than a year	geen gegevens	geen gegevens
Maya Hari	Independent Director	less than a year	geen gegevens	geen gegevens
Mandar Vaidya	Independent Director	2.3yrs	₹9.30m	geen gegevens
Prathivadibhayankara Ramesh	Independent Director	3.3yrs	₹10.00m	geen gegevens
Balram Bhargava	Independent Director	less than a year	geen gegevens	geen gegevens
Abhijit Joshi	Additional Non-Executive Director	less than a year	geen gegevens	geen gegevens

2.8yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CIPLA wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.8 jaar), wat duidt op een nieuw bestuur.

Cipla Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Cipla Limited Announces Executive Appointments

Cipla Limited Announces Resignation of M K Hamied as Vice Chairman and Non-Executive Director, Effective October 29, 2024

Cipla Limited Announces Retirement of S. Radhakrishnan, Non-Executive Director

Cipla Limited Approves the Appointment of Dr. Balram Bhargava as an Independent Director

Cipla Limited, Annual General Meeting, Aug 20, 2024

Cipla Limited Announces Retirement of S. Radhakrishnan as Non-Executive Director

Recent updates

Cipla Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Second quarter 2025 earnings: EPS exceeds analyst expectations

Cipla, Alkem Laboratories Reportedly in Final Lap to Buy SMT

Cipla Limited Announces Executive Appointments

Cipla Limited to Report Q2, 2025 Results on Oct 29, 2024

Cipla Limited's (NSE:CIPLA) Share Price Could Signal Some Risk

Cipla Limited Announces Resignation of M K Hamied as Vice Chairman and Non-Executive Director, Effective October 29, 2024

Cipla Limited Announces Retirement of S. Radhakrishnan, Non-Executive Director

Cipla Limited to Report Q1, 2025 Results on Jul 26, 2024

Cipla (NSE:CIPLA) Is Increasing Its Dividend To ₹13.00

Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA

Cipla's (NSE:CIPLA) Upcoming Dividend Will Be Larger Than Last Year's

Cipla Limited Approves the Appointment of Dr. Balram Bhargava as an Independent Director

Promoter Group Entities Reportedly Likely to Sell 2.5% Stake in Cipla worth INR 26.37 Billion via Block Deals

Earnings Update: Cipla Limited (NSE:CIPLA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Dividend increased to ₹13.00

Cipla Limited, Annual General Meeting, Aug 20, 2024

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

Cipla Limited Announces Retirement of S. Radhakrishnan as Non-Executive Director

With EPS Growth And More, Cipla (NSE:CIPLA) Makes An Interesting Case

Cipla Limited to Report Q4, 2024 Results on May 10, 2024

Cipla Limited Appoints Rajeev Kumar Sinha as Senior Management Personnel and Global Chief Manufacturing Officer, Effective April 1, 2024

Cipla Limited Appoints Venkata Sai Mungara as Senior Management Personnel and Global Head - Supply Chain, Effective from 1 April 2024

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Price target increased by 8.7% to ₹1,391

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Cipla Limited Announces Resignation of Ms. Samina Hamied as Executive Vice Chairperson

Third quarter 2024 earnings: EPS exceeds analyst expectations

Getting In Cheap On Cipla Limited (NSE:CIPLA) Is Unlikely

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Second quarter 2024 earnings released: EPS: ₹14.01 (vs ₹9.78 in 2Q 2023)

Torrent Pharmaceuticals Reportedly Bid to Acquire the Stake of Cipla Stalled over Valuation Differences

Torrent Pharma Calls the Reports of Cipla Acquisition as Speculative

Family Rift Clouds $7 Billion Sale of Cipla

Cipla Limited to Report Q2, 2024 Results on Oct 27, 2023

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Blackstone Reportedly Withdraws Plan to Acquire Founders' Stake in Cipla

Torrent Pharma Reportedly in Advance Talks with CVC Capital to Buyout Cipla Promoters

Cipla's Founding Family's Stake Sale Reportedly in Jeopardy over $13 Billion Valuation Target

Bain Capital Reportedly Approaches Dr. Reddy's Laboratories to Explore Joint Bid to Buy Out the Promoters of Cipla

Torrent Pharmaceutical Leads in the Race to Acquire Cipla

Torrent Reportedly in Top Gear to Close Out Cipla Buyout, in Talks with PES, Banks for Funds

Torrent Reportedly Joins Fray for Hamied Family Stake in Cipla

Blackstone Reportedly to Submit Bid for over 33% Stake in Cipla

Does Cipla (NSE:CIPLA) Have A Healthy Balance Sheet?

Cipla Promoters Reportedly Mull Stake Sale to Top PE Firms Blackstone, Baring Asia

Cipla Limited Announces Change in Management

Full year 2023 earnings: EPS misses analyst expectations

Cipla Limited, Annual General Meeting, Aug 10, 2023

Cipla Limited to Report Q1, 2024 Results on Jul 26, 2023

Shibam Group Holding Limited entered into a binding term sheet to acquire additional 51% stake in Saba Investment Ltd from Cipla Limited (NSEI:CIPLA) for $6.5 million.

Full year 2023 earnings: EPS misses analyst expectations

Cipla Limited Announces Resignation of Peter Mugyenyi as Independent Director, Effective May 13, 2023

Is Cipla (NSE:CIPLA) A Risky Investment?

A Look At The Fair Value Of Cipla Limited (NSE:CIPLA)

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Cipla Limited Announces the Launch of Cippoint

Cipla Limited to Report Q3, 2023 Results on Jan 25, 2023

Cipla (NSE:CIPLA) Has A Pretty Healthy Balance Sheet

Cipla Limited and Cipla Usa Inc. Announces the Launch of Leuprolide Acetate Injection Depot 22.5Mg

Price target increased to ₹1,208

Price target increased to ₹1,202

Second quarter 2023 earnings: EPS exceeds analyst expectations

Cipla Limited to Report Q2, 2023 Results on Nov 04, 2022

Cipla Limited Receives the Establishment Inspection Report Indicating Closure of the Inspection

Cipla Limited Declares Final Dividend for the Financial Year Ended March 31, 2022

Cipla Limited (NSEI:CIPLA) agreed to acquire additional 13.10% stake in Jiangsu Acebright Pharmaceutical Co. Limited for USD 16.40 million.

Estimating The Fair Value Of Cipla Limited (NSE:CIPLA)

Cipla Limited Announces Executive Changes